25th Annual Pharmacy Practice Seminar
Holiday Inn SunSpree Resort
1706 N. Lumnia Ave. Wrightsville Beach, NC 28480
www.wrightsville.sunspreeresorts.com or 877.330.5050 for Reservations
**Mention that you are part of this seminar for discounted room rates**
***SPECIAL RATE for GOLFERS!*** Mention that you are part of our program and play 18 holes at Cape Fear National Golfcourse for only $55 per person (cart and free bag of range balls included)
**Stay in touch! Bring your laptop- wireless connections are free in your room and meeting spaces!**
Click here to Register
Friday, August 27, 2010
8:00am-6:00pm MTM - Delivering Medication Therapy Management Services in the Community
an APhA Certificate Program
ACPE# 202-9999-07-089-H04-P (1.0CEU)
ACPE# 202-9999-07-236-L04-P (0.8CEU)
ACPE# 202-9999-09-098-H04-P (0.3CEU)
Click here for Activity Description and Goals
Leigh Foushee, PharmD, CDE
Associate Director of Pharamcotherapy Services, WAKE AHEC
Joan Settlemyer, PharmD
Network Coordinator, American Health Care
1:00pm-4:30pm Immunization Update
ACPE# 0046-9999-10-139-L04-P (0.3CEUs)
An update course for pharmacists who are currently certified Immunizers
*will satisfy CE requirements to maintain Immunization certification*
Macary W. Marciniak, PharmD
Clinical Assistant Professor, UNC Eshleman School of Pharmacy
Objectives: Read and interpret recommended immunization schedules.
Identify and describe common immunizations administered by
pharmacists, including indications, contraindications, side effects
and administration. Identify available resources for immunizing
pharmacists. Explain the legal and regulatory for immunizing
pharmacists. Discuss the roles pharmacists play regarding
immunizations. State immunization rates for health care workers
in the United States.
Saturday, August 28, 2010
7:00am Registration and Continental Breakfast
7:45am Welcome and Announcements
Chronic Disease Management Updates
ACPE# 0046-9999-10-113-L04-P (0.3CEUs)
See Objectives below for each topic
8:00am-8:45am Therapeutic Update: Hyperlipidemia
Kristen Bova-Campbell, PharmD
Clinical Pharmacist, Duke University Hospital
Clinical Assistant Professor, UNC Eshleman School of Pharmacy
Objectives: Review the ATP III guidelines and practical pearls for
treatment of hyperlipidemia. Classify cardiovascular disease
risk based on C-reactive protein and carotid intima-media
thickness. Analyze the implications of recent trials on the
current clinical practice in the management of hyperlipidemia
8:45am-9:30am Hypertension Management 2010
A. Wayne Pittman, MS Pharm
Professor for Pharmacotherapy, UNC Eshleman School of Pharmacy
Objectives: Review current guidelines (JNC7) for the pharmacologic
treatment of hypertension and discuss major issues
anticipated to impact JNC 8. Discuss the place of
combination therapy in the management of hypertension.
Indicate blood pressure goals for special populations of
patients who have hypertension.
9:30am-10:15am Overcoming Everyday Challenges in Achieving Optimal Therapy for
Heart Failure Patients
Jo Ellen Rodgers, PharmD
Clinical Associate Professor, UNC Eshelman School of Pharmacy
Objectives: Describe the components of standard HF therapy including
adjunct therapies for select patients Assure optimal
prescribing of standard therapies for the management of HF
in special populations. Optimize therapeutic descision
making for common HF comorbidities
10:15am Break
10:30am-11:15am Udpates in Diabetes for 2010: Applications in Practice
Philip Rodgers, PharmD, BCPS, CDE, CPP, FCCP
Director of Pharmacy Education, Duke AHEC
Clinical Associate Professor, UNC Eshelman School of Pharmacy
Objectives: Describe new understanding of pathophysiology and
complications of diabetes for 2010. Explain the recent
changes in the A1c measurement and its relationship to
diagnosis and its correlation to overall glycemic control and
other goals. Interpret and apply the results of recent major
diabetes trialswith regard to the relationship between
glycemic control and macrovascular and microvascular
complications and mortality. Evaluate the clinical application
of new information that challenges conventional thinking about
the use of asprin in the primary prevention of cardiovascular
disease in diabetes. Compare and contrast the use of new
drugs for diabetes, saxaglipitin and liraglutide, to traditional
antihyperglycemic drug therapies.
11:15pm Brunch
12:15pm-1:00pm Tobacco Abuse Cessation: Tools to make a Difference
ACPE# 0046-9999-10119-L04-P (.075 CEUs)
Peter G. Koval, PharmD, BCPS, CPP
Clinical Associate Professor, UNC Eshelman School of Pharmacy
Moses Cone Family Medicine Residency Program, Greensboro AHEC
Objectives: State the prevalence of tobacco use in North Carolina. Give
rational recommendations for pharmacologic management
of nicotine withdrawal, including indications, dose, route,
potential adverse effects and patient education. Effectively
motivate tobacco users to quit smoking. Describe obstacles
to smoking cessation and quantify the importance of
extensive counseling to help patients quit tobacco. Apply
tobacco cessation strategies to chew tobacco.
Sunday, August 29, 2010
7:15am Continental Breakfast
7:45am-8:45am What's New in OTCs?
ACPE# 0046-9999-10-117-L04-P (.1CEUs)
Stefanie Ferreri, PharmD, CDE, FAPhA
Clinical Associate Professor, UNC Eshelman School of Pharmacy
Objectives: Describe nonprescription agents introduced to the
market place in the last two years. Discuss products that may
be available without a prescription in the future. Describe
self-treatment issues posed by product-line extensions.
Develop a strategy to keep up with evolving self-care trends
and non-prescription products.
8:45am-9:45am Pharmacy Law and NC Board of Pharmacy Update
ACPE# 0046-9999-10-118-L03-P (.1CEUs)
Rebecca Chater, PharmD
9:45am Break
10:15am-11:45am Workshop I (Selected at Registration)
A. Top 10 Issues in Education, Counseling, Monitoring and Recommending
Therpay for Patients with Asthma
ACPE# 0046-9999-10-120-L04-P (.15CEUs)
Dennis Williams, PharmD
Associate Professor, UNC Eshelman School of Pharmacy
Objectives: Evaluate as asthma medication regimen for
appropriatness related to asthma control. Assess
potential challenges associated with the use of inhalation
devices. Describe a strategy to discuss safety concerns of
asthma medications with a patient.
B. Antibiotic Basics
ACPE# 0046-9999-10-116-L04-P (.15CEUs)
Ralph Raasch, PharmD
Associate Professor, UNC Eshelman School of Pharmacy
Objectives: Pharmacists- Given different patients with history, physcial
findings and laboratory data consistent wuth a bacterial
infection at different sites, propose a rationale that explains
the common causative bacterial etiologies at each site.
Formulate a listing of organisms that are commonly
causative of infections at each selected site. Create a
listing of considerations that should be evaluated when
selecting an appropriate antimocrobial regimen for a
given patient. Apply the information that arises from the
considerations in the previous objective in making an
antibiotic selection for a specific patient case. Assess a
patient case for the possible reasons for the lack of
response to a selected regimen of antibiotic therapy.
Objectives: Technicians- Same as Pharmacist Objectives
C. Updates on Prescription Drug Abuse
ACPE# 0046-9999-10-114-L04-P (.15CEUs)
Timothy J. Ives, PharmD, MPH, BCPS, FCCP, CPP
Professor, UNC Eshelman School of Pharmacy
Objectives: Provide information regarding misuse of some of the most
widely abused prescription and over the counter (OTC)
medications. Describe non-medical misuse, abuse, and
dependency of prescription medications. Identify at least
one solution for the treatment and prevention of prescription
and OTC drug abuse.
D. New Pharmacological Agents
ACPE # 0046-9999-10-115-L04-P (.15CEUs)
Debra Wobbleton-Kemp, PharmD, BCPS
Clinical Assistant Professor
Objectives: Identify new agents which have recently entered the US market
and are of significant pharmacotherpaeutic advancement.
Describe the mechanism(s) of action of these agents, typical
dose(s) used common adverse effects, special patient
instructions monitoring parameters and/or
contridictions associated with their use. Compare and
contrast the new agents with products used for the same
indication(s).
E. Lab Values
ACPE# 0046-9999-10-121-L04-P (.15CEUs)
Amber Peoples, PharmD
Assistant Professor, Campbell University College of Pharmacy & Health
Sciences
Objectives: Describe the factors that affect reference limits or lab values.
Evaluate abnormal lab values for medication related causes.
Discuss the role of MDRD and Cockroft-Gault in the treatment of
patients with kidney disease. Calculate eAG, corrected calcium
and reticulocyte index. Explain the clinical impact of BNP, CTx
and CRP on medication therapy..
11:45am Break
12:00pm-1:30pm Workshop II
Choose from list above
1:30pm Adjourn
_______________________________________________________________________________
25th Annual Pharmacy Practice Seminar
Target Audience: Pharmacists in community pharmacy, Ambulatory care and long term care practice
Program Goal: This program will provide pharmacists an update on current pharmacotherapy and pharmaceutical care concerns in primary care community/ambulatory care pracitce.
Learning Objectives:
Coming Soon!
Refund Policy: Refunds less a $50.00 administrative fee if cancellation is received in our office by August 13, 2010. Thereafter, no refunds will be issued. If substitutions are necessary, please call 919.843.4028 prior to August 23, 2010 to ensure correct registration materials. CE Credit: To receive credit, attendance MUST be acknowledged at the registration desk upon arrival at the program. NO CE statements wil be mailed to participants. Participants will complete online evaluation of program and print ceritifcates on their own.
General Information:
Adverse Weather Policy: If a hurricane is threatening the Wrightsville Beach area, please call the Eshelman School of Pharmacy CE office (919.843.4028) no later than Thursday morning, 08/26/2010, to determine the programs' status. We will not be able to contact each participant individually concerning cancellation of this program.
Program Coordinators:
Stephen C. Dedrick. MS
Director, Continuing Education
UNC Eshelman School of Pharmacy
Krista Williams
Executive Manager, CE
UNC Eshelman School of Pharmacy
Bruce R. Canaday, PharmD
Director of Pharmacotherpay
Southeast AHEC
Click here to register
